scispace - formally typeset
A

Anders Aune Tveita

Researcher at Oslo University Hospital

Publications -  60
Citations -  6573

Anders Aune Tveita is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 18, co-authored 41 publications receiving 5718 citations. Previous affiliations of Anders Aune Tveita include University of Oslo & Vestre Viken Hospital Trust.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Ole Audun Werner Haabeth, +10 more
- 15 Apr 2014 - 
TL;DR: While the priming phase of CD4+ T cells appears similar for MHCIIPOS and MHCIINEG tumors, the killing mechanisms are different and unresolved issues and directions for future research are addressed.
Journal ArticleDOI

National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.

Marius Myrstad, +9 more
- 13 Jul 2020 - 
TL;DR: In this paper, the performance of the National Early Warning Score 2 (NEWS2) and other clinical risk scores at admission to predict risk of severe disease and in-hospital mortality in patients with covid-19 was evaluated.
Journal ArticleDOI

Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.

Even Fossum, +9 more
- 01 Feb 2015 - 
TL;DR: Targeting of dimeric fusion vaccine molecules to CD8α+ DCs using Xcl1 represents a novel and promising method for induction of protective CD8+ T‐cell responses.
Journal ArticleDOI

Local Delivery of Ox40l , Cd80 , and Cd86 mRNA Kindles Global Anticancer Immunity.

Ole Audun Werner Haabeth, +10 more
- 01 Apr 2019 - 
TL;DR: In this article, the authors used charge-altering releasable transporters (CART) for local intratumoral delivery of mRNA coding for costimulatory and immune-modulating factors.